Hossein Hosseini Selected Research

Hossein Hosseini Research Topics

Disease

8	Inflammation (Inflammations) 03/2024 - 04/2006
5	Neoplasms (Cancer) 05/2024 - 05/2021
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 03/2023
3	Non-alcoholic Fatty Liver Disease 10/2023 - 01/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 01/2021
3	Atherosclerosis 10/2023 - 12/2020
3	Obstructive Sleep Apnea 01/2023 - 12/2021
3	Type 2 Diabetes Mellitus (MODY) 05/2022 - 03/2020
2	Melanoma (Melanoma, Malignant) 05/2024 - 12/2023
2	Insulin Resistance 04/2024 - 05/2022
2	Hemorrhage 02/2024 - 11/2018
2	Obesity 10/2023 - 01/2020
2	Thrombosis (Thrombus) 07/2023 - 01/2021
2	Infections 07/2021 - 09/2015
1	T-Cell Lymphoma (Lymphoma, T Cell) 05/2024
1	Esophageal Neoplasms (Esophageal Cancer) 05/2024
1	Postoperative Pain 02/2024
1	Tinea Versicolor (Pityriasis Versicolor) 01/2024
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024
1	Colonic Neoplasms (Colon Cancer) 07/2023
1	Myocardial Infarction 07/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Birth Weight (Birth Weights) 07/2022
1	Pre-Eclampsia (Preeclampsia) 07/2022
1	Glioma (Gliomas) 05/2021
1	Hydrocephalus (Hydrocephaly) 05/2021
1	Hypertension (High Blood Pressure) 12/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2020
1	Pathologic Constriction (Stenosis) 12/2020
1	Bronchitis 05/2020
1	Tenosynovitis 02/2020
1	Thalassemia 01/2016
1	Rheumatoid Arthritis 01/2016
1	Poisoning 08/2015
1	Critical Illness (Critically Ill) 08/2015
1	Emphysema 04/2006

Drug/Important Bio-Agent (IBA)

7	ResveratrolIBA 04/2024 - 01/2020
6	LipidsIBA 05/2024 - 07/2017
4	AntioxidantsIBA 04/2024 - 01/2016
3	Malondialdehyde (Propanedial)IBA 04/2024 - 12/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2024 - 10/2023
2	Proteins (Proteins, Gene)FDA Link 05/2024 - 10/2021
2	piperineIBA 03/2024 - 03/2023
2	CurcuminIBA 03/2024 - 03/2023
2	ChitosanIBA 12/2023 - 07/2023
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 11/2022
2	VaccinesIBA 02/2020 - 09/2015
1	Terpenes (Terpenoids)IBA 05/2024
1	Purinergic Receptors (Receptors, Purine)IBA 05/2024
1	Mevalonic Acid (Mevalonate)IBA 05/2024
1	Therapeutic UsesIBA 04/2024
1	Analgesics (Analgesic Drugs)IBA 02/2024
1	Labetalol (Normodyne)FDA LinkGeneric 02/2024
1	Lidocaine (Xylocaine)FDA LinkGeneric 02/2024
1	Inulin FDA Link 01/2024
1	liposomal amphotericin B FDA Link 01/2024
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2024
1	Clotrimazole (Lotrimin)FDA LinkGeneric 01/2024
1	citral (neral)IBA 12/2023
1	Volatile Oils (Essential Oils)IBA 12/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2023
1	Matrix Metalloproteinases (MMPs)IBA 07/2023
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 07/2023
1	LecithinsIBA 07/2023
1	allicinIBA 07/2023
1	CholesterolIBA 03/2023
1	oxidized low density lipoproteinIBA 03/2023
1	AcidsIBA 01/2023
1	Nicotinamide PhosphoribosyltransferaseIBA 07/2022
1	Insulin ReceptorIBA 05/2022
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 05/2022
1	Glucose (Dextrose)FDA LinkGeneric 05/2022
1	Asparaginase (Elspar)FDA Link 01/2022
1	EnzymesIBA 01/2022
1	Combined VaccinesIBA 07/2021
1	Attenuated VaccinesIBA 07/2021
1	Histones (Histone)IBA 05/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Streptokinase FDA Link 01/2021
1	Ranolazine FDA Link 12/2020
1	Inactivated VaccinesIBA 05/2020
1	C-Reactive ProteinIBA 03/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	JNK Mitogen-Activated Protein KinasesIBA 01/2020
1	PolyphenolsIBA 01/2020
1	AnticoagulantsIBA 11/2018
1	Warfarin (Coumadin)FDA LinkGeneric 11/2018
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	CytokinesIBA 01/2016
1	Nigella sativa oilIBA 01/2016
1	SodiumIBA 08/2015
1	SmokeIBA 04/2006

Therapy/Procedure

5	Therapeutics 05/2024 - 08/2015
2	Stents 07/2023 - 12/2020
1	Continuous Positive Airway Pressure 01/2023
1	Injections 11/2018